AI Article Synopsis

  • - Fusion sarcoma is a recently classified type of round-cell sarcoma identified in the 2020 WHO classification, and it's typically treated through surgical removal.
  • - Currently, there is no standard treatment for locally advanced or metastatic fusion sarcoma, making effective therapies critical.
  • - A case study of a middle-aged male with pelvic fusion sarcoma treated with carbon ion radiotherapy showed promising results, maintaining stable disease for 13 months, indicating potential effectiveness of this treatment for advanced cases.

Article Abstract

fusion sarcoma is a type of round-cell sarcoma with fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors. In general, local disease is managed via surgical resection; however, at present, there is no standard therapy for locally advanced or metastatic disease. Here, we report our experience with a middle-aged male patient with pelvic fusion sarcoma who was treated with carbon ion radiotherapy and maintained stable disease for 13 months. The patient's clinical course suggests that carbon ion radiotherapy may be effective in patients with locally advanced fusion sarcoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033106PMC
http://dx.doi.org/10.1016/j.radcr.2024.03.070DOI Listing

Publication Analysis

Top Keywords

fusion sarcoma
16
carbon ion
12
ion radiotherapy
12
pelvic fusion
8
sarcoma treated
8
treated carbon
8
locally advanced
8
fusion
5
sarcoma
5
case pelvic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!